LRG Staff

About LRG Staff

This author has not yet filled in any details.
So far LRG Staff has created 569 blog entries.

National Organization for Rare Disorders Hosts Forum for FDA Commissioner and Patient Leaders

Food and Drug Commissioner Dr. Margaret Hamburg today conducted an unusual one-on-one dialogue with leaders of approximately 60 patient organizations at a forum hosted by the National Organization for Rare Disorders (NORD).

By |2019-12-26T14:30:48-05:00February 1st, 2011|News|

Latin American GIST Coalition, new challenges on the horizon for 2010

The year 2010 is gone, an important year for the Latin American GIST Coalition. In 2010 the Monterrey Declaration was signed during the first summit meeting of the group. The group had the privilege of meeting the LRG research team, who works on a daily basis to find the cure for GIST.

By |2019-12-26T14:29:52-05:00February 1st, 2011|News|

Masitinib Phase II Trial Reports Benefit in New GISTs

At the American Society of Clinical Oncology Gastrointestinal (GI ASCO) Symposium January 20, 2011, researchers reported progression-free and overall survival benefit in newly diagnosed advanced GIST patients in an ongoing Masitinib (AB1010) Phase II trial in France.

By |2019-12-26T14:27:42-05:00February 1st, 2011|Clinical Trials, News|

Clinical Trials update for February 2011

Bayer initiates a randomized Phase III trial of Regorafenib in GIST: On January 10, 2011 Bayer Healthcare in Berlin, Germany announced the initiation of a randomized phase III trial of Regorafenib (BAY 73-4506) for Gastrointestinal Stromal Tumor patients.

By |2019-12-26T14:26:51-05:00February 1st, 2011|Clinical Trials, News, Stivarga|
Go to Top